-
One-stop clinic for assessment of risk of chromosomal defects at 12 weeks of gestation.
Nicolaides KH, Bindra R, Heath V, Cicero S.
J Matern Fetal Neonatal Med 2002;12:9-18. -
Platelet changes and subsequent development of pre-eclampsia and fetal growth restriction in women with abnormal uterine artery Doppler screening.
Missfelder-Lobos H, Teran E, Lees C, Albaiges G, Nicolaides KH.
Ultrasound Obstet Gynecol 2002;19:443-8. -
Respiratory function in singleton and twin pregnancy.
McAuliffe F, Kametas N, Costello J, Rafferty GF, Greenough A, Nicolaides K.
BJOG 2002;109:765-9. -
Maternal serum insulin-like growth factor binding protein-1 in pregnancy at high altitude.
Krampl E, Kametas NA, McAuliffe F, Cacho-Zegarra AM, Nicolaides KH.
Obstet Gynecol 2002;99:594-8. -
Flow-mediated dilatation of the brachial artery in pregnancy at high altitude.
Kametas NA, Savvidou MD, Donald AE, McAuliffe F, Nicolaides KH.
BJOG 2002;109:930-7. -
Fetal cardiac abnormalities identified prior to 14 weeks' gestation.
Huggon IC, Ghi T, Cook AC, Zosmer N, Allan LD, Nicolaides KH.
Ultrasound Obstet Gynecol 2002;20:22-9. -
Monozygotic twins discordant for body stalk anomaly.
Daskalakis GJ, Nicolaides KH.
Ultrasound Obstet Gynecol 2002;20:79-81. -
Fetal nasal bone length in chromosomally normal and abnormal fetuses at 11-14 weeks of gestation.
Cicero S, Bindra R, Rembouskos G, Tripsanas C, Nicolaides KH.
J Matern Fetal Neonatal Med 2002;11:400-2. -
Screening for chromosomal defects by fetal nuchal translucency at 11 to 14 weeks.
Bindra R, Heath V, Nicolaides KH.
Clin Obstet Gynecol 2002;45:661-70. -
One-stop clinic for assessment of risk for trisomy 21 at 11-14 weeks: a prospective study of 15 030 pregnancies.
Bindra R, Heath V, Liao A, Spencer K, Nicolaides KH.
Ultrasound Obstet Gynecol 2002;20:219-25. -
Outcome of antenatally diagnosed talipes equinovarus in an unselected obstetric population.
Bakalis S, Sairam S, Homfray T, Harrington K, Nicolaides K, Thilaganathan B.
Ultrasound Obstet Gynecol 2002;20:226-9. -
Intrapartum sonography to determine fetal head position.
Akmal S, Tsoi E, Kametas N, Howard R, Nicolaides KH.
J Matern Fetal Neonatal Med 2002;12:172-7. -
Pathophysiology of increased nuchal translucency in chromosomally abnormal fetuses.
von Kaisenberg CS, Brand-Saberi B, Jonat W, Nicolaides KH.
Der Gynäkologe 1999;32:193-199. -
Lymphatic vessel hypoplasia in fetuses with Turner syndrome.
von Kaisenberg CS, Nicolaides KH, Brand-Saberi B.
Hum Reprod 1999;14:823-6. -
Screening for trisomy 18 by fetal nuchal translucency and maternal serum free beta -hCG and PAPP-A at 10-14 weeks of gestation.
Tul N, Spencer K, Noble P, Chan C, Nicolaides K.
Prenat Diagn 1999;19:1035-42. -
A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH.
Ultrasound Obstet Gynecol 1999;13:231-7. -
Cervical length at 23 weeks in twins in predicting spontaneous preterm delivery.
Souka AP, Heath V, Flint S, Sevastopoulou I, Nicolaides KH.
Obstet Gynecol 1999;94:450-4. -
Increased nuchal translucency in trisomy 13 fetuses at 10-14 weeks of gestation.
Snijders RJ, Sebire NJ, Nayar R, Souka A, Nicolaides KH.
Am J Med Genet 1999;86:205-7. -
Maternal age and gestation-specific risk for trisomy 21.
Snijders RJ, Sundberg K, Holzgreve W, Henry G, Nicolaides KH.
Ultrasound Obstet Gynecol 1999;13:167-70. -
Nuchal translucency as a marker of congenital heart disease.
Perdu M, Hyett JA, Sharland G, Snijders RS, Nicolaides KH.
Contracept Fertil Sex 1999;27:I-V.